Skip to main content
. Author manuscript; available in PMC: 2018 Mar 21.
Published in final edited form as: Biochemistry. 2017 Dec 20;57(3):286–294. doi: 10.1021/acs.biochem.7b00874

Figure 4. Propionamide modification of cysteines represents a minor fraction of NEM and NEM-d5 modification.

Figure 4

The data shown for Cys43 and Cys51 are: 1, NEM-d5 modification extent of apo-hVKOR protein, i.e., NEM-d5/(NEM+NEM-d5); 2, NEM-d5 modification extent of warfarin-treated hVKOR; 3, propionamide modification extent of apo-hVKOR; and 4, propionamide modification extent of warfarin-treated hVKOR.